Safety and immunogenicity of preexposure rabies vaccination in children infected with human immunodeficiency virus type 1

Clinical Infectious Diseases

Volumn 30, Issue 1, 2000, Pages 218-

  Thisyakorn, Usa ^a   Pancharoen, Chitsanu ^a   Ruxrungtham, Kiat ^a   Ubolyam, Sasiwimol ^a   Khawplod, Pakamazt ^a   Tantawichien, Terapong ^a   Phanuphak, Praphan ^a   Wilde, Henry ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; RABIES VACCINE;

ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; DRUG SAFETY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN TISSUE; IMMUNOGENICITY; PRIORITY JOURNAL; RABIES; VACCINATION;

ANTIBODIES, VIRAL; CASE-CONTROL STUDIES; CHILD, PRESCHOOL; HIV INFECTIONS; HIV-1; HUMANS; RABIES; RABIES VACCINES; RABIES VIRUS; VACCINATION;

EID: 0033971805     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/313610     Document Type: Article

References (5)

1. Thisyakorn U, Paupanwatana S, Chotpitayasunondh T, et al. Perinatal HIV infection in Thailand. Proceedings of International Symposium on Pediatric AIDS in Thailand: a public health and social dilemma. Cambridge: Harvard AIDS Institute, 1995:23-7.
2. Phanuphak P, Chutiwongse S. Should we systematically anticipate rabies immunization of children in endemic countries? [abstract]. Symposium and seminar on vaccination, presented at the 19th International Congress of Pediatrics (Lyon, France). Paris, France: Institut Merieux, 1989:19-20.
3. Smith JS, Yager PA, Baer GM. A rapid reproducible test for determining rabies neutralizing antibody. Bull WHO 1973; 48:535-41.
4. Lane HC, Masur H, Edgar LC, et al. Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N Engl J Med 1983; 309:453-8.
5. World Health Organization. Report of a World Health Organization consultation on intradermal application of human rabies vaccine. Geneva: World Health Organization, 1995 (WHO/Rab/Res/95.47).